Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Sclerosis
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 289 active Multiple Sclerosis trials
Impact of Cionic Neural Sleeve on Mobility in Multiple Sclerosis
Study Type: Interventional
Meeting an Unmet Need in Multiple Sclerosis
Study Type: Interventional
Outcomes of Group Dance and Movement Training in Ambulatory MS Patients
Study Type: Interventional
Exercise Training, Cognition, and Mobility in Older Adults With Multiple Sclerosis
Study Type: Interventional
Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes
Study Type: Interventional
A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis
Study Type: Interventional Phase 3
Study to Evaluate the Maintenance of Efficacy When Transitioning From Anti-CD20 Therapy to Ublituximab (ENHANCE)
Study Type: Interventional Phase 3
There are 289 active Multiple Sclerosis trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now